Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26823559)
Watch
English
Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
title
Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
(English)
1 reference
stated in
PubMed
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
Robert B. Sims
series ordinal
1
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
19 June 2012
1 reference
stated in
PubMed
published in
Vaccine
1 reference
stated in
PubMed
volume
30
1 reference
stated in
PubMed
issue
29
1 reference
stated in
PubMed
page(s)
4394-7
1 reference
stated in
PubMed
cites work
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
CD54 is a surrogate marker of antigen presenting cell activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Immunotherapies in clinical trials: do they demand different evaluation tools?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.058
retrieved
7 January 2021
Identifiers
DOI
10.1016/J.VACCINE.2011.11.058
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4619221
OpenCitations bibliographic resource ID
4619221
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4619221
PubMed ID
22122856
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4619221
ResearchGate publication ID
51832136
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
